These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29559537)

  • 21. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerosol Delivery Devices for Obstructive Lung Diseases.
    Pleasants RA; Hess DR
    Respir Care; 2018 Jun; 63(6):708-733. PubMed ID: 29794206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge of and technique for using inhalation devices among asthma patients and COPD patients.
    Souza ML; Meneghini AC; Ferraz E; Vianna EO; Borges MC
    J Bras Pneumol; 2009 Sep; 35(9):824-31. PubMed ID: 19820807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaler devices for patients with COPD.
    Fink JB; Colice GL; Hodder R
    COPD; 2013 Aug; 10(4):523-35. PubMed ID: 23537191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
    Aggarwal B; Gogtay J
    Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers.
    Hanania NA; Wittman R; Kesten S; Chapman KR
    Chest; 1994 Jan; 105(1):111-6. PubMed ID: 8275720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ADMIT series - issues in inhalation therapy. 6) Training tools for inhalation devices.
    Lavorini F; Levy ML; Corrigan C; Crompton G;
    Prim Care Respir J; 2010 Dec; 19(4):335-41. PubMed ID: 21049263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of nebulized therapy in the management of COPD: evidence and recommendations.
    Dhand R; Dolovich M; Chipps B; Myers TR; Restrepo R; Farrar JR
    COPD; 2012 Feb; 9(1):58-72. PubMed ID: 22292598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Breathing New Life Into Chronic Obstructive Pulmonary Disease (COPD)" - Results From An Online Survey Of UK Patients.
    Titmarsh S; Poliziani M; Russell RE
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2799-2807. PubMed ID: 31824144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of hospice nurses' technique in the use of inhalers and nebulizers.
    Scarpaci LT; Tsoukleris MG; McPherson ML
    J Palliat Med; 2007 Jun; 10(3):665-76. PubMed ID: 17592978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing drug delivery in COPD: The role of inhaler devices.
    Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
    Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Effects of Organized Education for Patients with Chronic Obstructive Pulmonary Disease.
    Jang JG; Kim JS; Chung JH; Shin KC; Ahn JH; Lee MS; Bang SH; Park DY; Nam MJ; Jin HJ; Lee KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2603-2609. PubMed ID: 31819396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled drug delivery in the hands of the patient.
    Lavorini F
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):414-8. PubMed ID: 25238005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD.
    Chrystyn H; Small M; Milligan G; Higgins V; Gil EG; Estruch J
    Respir Med; 2014 Feb; 108(2):358-65. PubMed ID: 24209768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidance on handheld inhalers in asthma and COPD guidelines.
    Dekhuijzen PN; Bjermer L; Lavorini F; Ninane V; Molimard M; Haughney J
    Respir Med; 2014 May; 108(5):694-700. PubMed ID: 24636812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Customizing inhaled therapy to meet the needs of COPD patients.
    Fromer L; Goodwin E; Walsh J
    Postgrad Med; 2010 Mar; 122(2):83-93. PubMed ID: 20203459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD.
    Vincken W; Dekhuijzen PR; Barnes P;
    Prim Care Respir J; 2010 Mar; 19(1):10-20. PubMed ID: 19890594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.